ATE125706T1 - Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis. - Google Patents

Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.

Info

Publication number
ATE125706T1
ATE125706T1 AT86200822T AT86200822T ATE125706T1 AT E125706 T1 ATE125706 T1 AT E125706T1 AT 86200822 T AT86200822 T AT 86200822T AT 86200822 T AT86200822 T AT 86200822T AT E125706 T1 ATE125706 T1 AT E125706T1
Authority
AT
Austria
Prior art keywords
arthrosis
treatment
pharmaceutical compositions
compositions containing
compositions
Prior art date
Application number
AT86200822T
Other languages
English (en)
Inventor
Sergio Rosini
Luciano Fontanelli
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Application granted granted Critical
Publication of ATE125706T1 publication Critical patent/ATE125706T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT86200822T 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis. ATE125706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Publications (1)

Publication Number Publication Date
ATE125706T1 true ATE125706T1 (de) 1995-08-15

Family

ID=11302741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86200822T ATE125706T1 (de) 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.

Country Status (6)

Country Link
US (1) US4814326A (de)
EP (1) EP0203649B1 (de)
AT (1) ATE125706T1 (de)
DE (1) DE3650358T2 (de)
HK (1) HK1006154A1 (de)
IT (1) IT1187828B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
FI89365C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
JPH05194563A (ja) * 1991-07-12 1993-08-03 Hoechst Ag 置換アミノエタン−１，１−ビスホスホン酸およびアミノエタン−１，１−アルキルホスフィノホスホン酸
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US6410782B1 (en) * 1997-07-09 2002-06-25 Geange Ltd. Diphosphonic acid salts for the treatment of osteoporosis
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
PL351674A1 (en) * 1999-05-21 2003-05-19 Novartis Ag Use of bisphosphonic acids for treating angiogenesis
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (de) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmazeutische Zusammensetzungen enthaltend Clodronate mit hoher lokaler Verträglichkeit bei intramuskulärer Verabreichung
KR20030083725A (ko) * 2001-03-01 2003-10-30 에미스페어 테크놀로지스, 인코포레이티드 비스포스포네이트 전달용 조성물
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
TWI315982B (en) * 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
ITTO20020406A1 (it) * 2002-05-13 2003-11-13 Chiesi Farma Spa Formulazioni di bisfosfonati ad uso iniettabile.
WO2003101462A2 (en) * 2002-05-31 2003-12-11 Københavns Universitet Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
ITMI20052515A1 (it) 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
EP2240159A2 (de) * 2008-02-05 2010-10-20 Actavis Group PTC EHF Formulierungen von alendronat, herstellungs- und anwendungsverfahren dafür
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
EP4360627A1 (de) * 2022-10-26 2024-05-01 Institut National de la Santé et de la Recherche Médicale (INSERM) Behandlung von osteoarthritis mit comt-inhibitoren

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
US3471406A (en) * 1965-09-07 1969-10-07 Plains Chem Dev Co Detergent compositions containing methane tri and tetra phosphonic acid compounds
CA790610A (en) * 1965-12-28 1968-07-23 T. Quimby Oscar Diphosphonate compounds and detergent compositions
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
GB1421064A (en) * 1973-03-09 1976-01-14 Procter & Gamble Oral compositions for calculus retardation
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
EP0088462A3 (de) * 1982-03-01 1984-06-06 The Procter & Gamble Company Entzündungshemmende und antirheumatische Zusammensetzung mit Gehalt an einem Organophosphonat und einem Steroiden
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate

Also Published As

Publication number Publication date
DE3650358D1 (de) 1995-09-07
IT1187828B (it) 1987-12-23
EP0203649A2 (de) 1986-12-03
IT8567478A0 (it) 1985-05-24
EP0203649A3 (en) 1989-12-06
HK1006154A1 (en) 1999-02-12
EP0203649B1 (de) 1995-08-02
US4814326A (en) 1989-03-21
DE3650358T2 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DE3584120D1 (de) Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
DK0725648T3 (da) Leverspecifikke farmaceutiske aktivstoffer
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
SE8802569D0 (sv) Improvements in or relation to somatostatins
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
DE68912589D1 (de) Mittel zur verbesserung des fettabbaus und verfahren zur verwendung.
ATE320270T1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
KR880008812A (ko) 항균성 동결건조 제제
RU94013606A (ru) Гемостимулятор

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties